Evidence map›Paper›PMID 40821366›Full record

ArticleRadiology case reports2025

Oncocytic carcinoma of the parotid gland: A rare malignancy with diagnostic and therapeutic challenges.

Youssef Azouaghe, Zakaria Haddadi, Majda Zohir, Youness Banana, Achraf Amine Sbai, Drissia Benfadil, Azeddine Lachkar, Fahd El Ayoubi El Idrissi

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Molecular imaging and radionuclide therapy · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Youssef AzouagheFaculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco.
Zakaria HaddadiFaculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco.
Majda ZohirFaculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco.
Youness BananaFaculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco.
Achraf Amine SbaiFaculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco.
Drissia BenfadilFaculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco.
Azeddine LachkarFaculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco.
Fahd El Ayoubi El IdrissiFaculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oncocytic carcinoma of the parotid gland is an exceptionally rare malignancy, accounting for approximately 0.18% of all salivary gland cancers. Its diagnosis is often delayed due to overlapping clinical and radiologic features with benign oncocytic tumors such as oncocytoma and Warthin tumor. We report the case of a 64-year-old man who presented with a progressively enlarging right parotid mass over 4 months, accompanied by new-onset facial nerve palsy and trismus. MRI revealed a multilobulated, ill-defined, heterogeneously enhancing mass in the superficial lobe of the right parotid gland, without overt signs of perineural spread. Despite the absence of clear radiological evidence of nerve invasion, intraoperative findings confirmed extensive tumor infiltration of the facial nerve, requiring its complete sacrifice. Histopathological examination, complemented by immunohistochemical analyses demonstrating strong CK7 and PAX8 expression, was essential in confirming the diagnosis of oncocytic carcinoma and distinguishing it from benign oncocytic lesions. This case highlights the limitations of conventional imaging in detecting perineural invasion and underscores the importance of integrating clinical, surgical, and detailed histopathologic evaluation, including immunohistochemistry, in managing atypical parotid tumors.

Indexed as

Facial paralysisMagnetic resonance imagingParotidectomyParotid neoplasmsRadiotherapy adjuvant

Identifiers

PMID40821366
PMCPMC12356298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.